Technology

Susan Coultas, PhD, and Preeya Gupta, MD, share their hopes for continued innovation in the ophthalmic space — including dry eye and retina — as well as the importance of the clinical research process.

S.K. Steven Houston III, MD, shares how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.

Michael X. Repka, MD, vice chair of clinical practice at Wilmer Eye Institute (Johns Hopkins University) speaks on the institution's latest protocol changes allowing for the resumption of elective surgery as well as the adaptations clinicians have had to make in order to ensure the continuation of clinical practice at Wilmer Eye Institute.

In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.

No matter the technology used, it is necessary to customize the implant choice based on the patient’s needs to achieve optimal refractive outcomes.

Emerging technology may be able to fill existing imaging diagnostic gaps

Retina specialists Caesar Luo, MD, of Bay Area Retina Associates (Walnut Creek, CA) and S.K. Steven Houston III, MD, of Florida Retina Institute, share their outlooks on retina innovation in the "year of the eye" amid a global pandemic.

COVID-19 pandemic is accelerating cultural paradigm shift for medical professionals

Machine-learning algorithms have potential to predict patients with nonproliferative diabetic retinopathy who will or will not improve over time.

Study results demonstrate effectiveness in treating dry age-related macular degeneration

Researchers must weigh emotional, financial, and reputational considerations

Technology is off to a good start, but improvements still needed

ASRS 2020 coverage: An augmented-reality device provides AMD patients with enhanced reading ability and facial recognition.

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye

With an eye on innovation, money is driving research of new therapies and devices.

Industry develops creative approaches to help increase patient medication adherence

Just as evolving technology is changing patients' visual demands, eye-care providers should increase their awareness and efforts to fill current gaps.

Panel discusses IOP monitoring, drug delivery, data collection

Research finds automated segmentation software examines OCT scans

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

New products increase the chance of early diagnosis

Physicians can discover, diagnose, document, treat diseases that might go undetected

ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).